Giles E. Hardingham
Affiliations: | University of Edinburgh, Edinburgh, Scotland, United Kingdom |
Area:
NMDA receptorsGoogle:
"Giles Hardingham"Mean distance: 15.85 (cluster 11) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Jiwaji Z, Márkus NM, McQueen J, et al. (2023) General anesthesia alters CNS and astrocyte expression of activity-dependent and activity-independent genes. Frontiers in Network Physiology. 3: 1216366 |
Baxter PS, Dando O, Hardingham GE. (2023) Differential splicing choices made by neurons and astrocytes and their importance when investigating signal-dependent alternative splicing in neural cells. Frontiers in Molecular Neuroscience. 16: 1214439 |
Booker SA, Simões de Oliveira L, Anstey NJ, et al. (2020) Input-Output Relationship of CA1 Pyramidal Neurons Reveals Intact Homeostatic Mechanisms in a Mouse Model of Fragile X Syndrome. Cell Reports. 32: 107988 |
Qiu J, Dando O, Febery JA, et al. (2020) Neuronal Activity and Its Role in Controlling Antioxidant Genes. International Journal of Molecular Sciences. 21 |
Hardingham GE. (2020) Targeting Synaptic NMDA Receptor Co-agonism as a Therapy for Alzheimer's Disease? Cell Metabolism. 31: 439-440 |
Zhao C, Devlin AC, Chouhan AK, et al. (2019) Mutant C9orf72 human iPSC-derived astrocytes cause non-cell autonomous motor neuron pathophysiology. Glia |
Bas-Orth C, Schneider J, Lewen A, et al. (2019) The mitochondrial calcium uniporter is crucial for the generation of fast cortical network rhythms. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X19887777 |
Booker SA, Domanski APF, Dando OR, et al. (2019) Altered dendritic spine function and integration in a mouse model of fragile X syndrome. Nature Communications. 10: 4813 |
Hardingham G. (2019) NMDA receptor C-terminal signaling in development, plasticity, and disease. F1000research. 8 |
Marwick KFM, Skehel PA, Hardingham GE, et al. (2019) The human NMDA receptor GluN2A variant influences channel blocker potency. Pharmacology Research & Perspectives. 7: e00495 |